Neurology · 2008 · 191 citations · 33 references
Life SciencesNeurologyNeuroscienceCognitive NeuroscienceDementiaNeuropsychologyAlzheimer DiseaseBiomarkers Of NeurodegenerationCognitive AgingCognitive ImpairmentNeurodegenerative DiseasesNeurodegenerative DisordersAlzheimer Disease ProgressionBrain RegionsFamily History Of DementiaGlucose Metabolism ImagingLate Onset Alzheimer DiseaseNeuropsychological DeclineNeuropsychological ImpairmentSubjects
BACKGROUND: At cross-section, cognitively normal individuals (NL) with a maternal history of late-onset Alzheimer disease (AD) have reduced glucose metabolism (CMRglc) on FDG-PET in the same brain regions as patients with clinical AD as compared to those with a paternal and a negative family history (FH) of AD. This longitudinal FDG-PET study examines whether CMRglc reductions in NL subjects with a maternal history of AD are progressive. METHODS: Seventy-five 50- to 82-year-old NL received 2-year follow-up clinical, neuropsychological, and FDG-PET examinations. These included 37 subjects with negative family history of AD (FH-), 9 with paternal (FHp), and 20 with maternal AD (FHm). Two subjects had parents with postmortem confirmed AD. Statistical parametric mapping was used to compare CMRglc across FH groups at baseline, follow-up, and longitudinally. RESULTS: At both time points, the FH groups were comparable for demographic and neuropsychological characteristics. At baseline and at follow-up, FHm subjects showed CMRglc reductions in the parieto-temporal, posterior cingulate, and medial temporal cortices as compared to FH- and FHp (p < 0.001). Longitudinally, FHm had significant CMRglc declines in these regions, which were significantly greater than those in FH- and FHp (p < 0.05). CONCLUSIONS: A maternal history of Alzheimer disease (AD) predisposes normal individuals to progressive CMRglc reductions in AD-vulnerable brain regions, which may be related to a higher risk for developing AD.
33
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Satoshi Minoshima, Bruno Giordani, Stanley Berent et al. · Annals of Neurology · 1997 · 1.8K citations · Full text
Medicine, Neurology, Neuroscience +17
Comparing Functional (PET) Images: The Assessment of Significant Change
Karl Friston, Chris Frith, Peter F. Liddle et al. · Journal of Cerebral Blood Flow & Metabolism · 1991 · 1.6K citations · Full text
Medicine, Neurology, Neuroscience +15
Mitochondrial Abnormalities in Alzheimer's Disease
Keisuke Hirai, Gjumrakch Aliev, Akihiko Nunomura et al. · Journal of Neuroscience · 2001 · 1.4K citations · Full text